Clinical Trial Update: Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating a single dose of Gruticibart to prevent thrombosis; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Drugs mentioned

• Gruticibart

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Thrombosis | Phase 2 | Status: NOT_YET_RECRUITING